Lupus causes chronic pain, fatigue, and potentially organ damage for 1.5 million Americans and is a challenge for researchers trying to find better treatments.
Regeneron’s $500M fund spotlights corporate venture’s influential role in biotech
When Regeneron announced a $500 million corporate venture capital fund last week, it was the first time in years that a storied large pharma had
April 23, 2024